S-40503: A SARM for Bone Healing

S-40503: The bone healing SARM. A review by

Looking for information on S-40503, a SARM that may be beneficial for bone health? Read our comprehensive review on to learn about its potential effects and recommended dosage. Make an ...


  1. Narayanan, R., Coss, C., Dalton, J. (2018). Development Of Selective Androgen Receptor Modulators (Sarms). Molecular and Cellular Endocrinology, (465), 134-142.
  2. Dodson, S., Baracos, V., Jatoi, A., Evans, W., Cella, D., Dalton, J., … & Steiner, M. (2011). Muscle Wasting In Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies. Annu. Rev. Med., 1(62), 265-279.
  3. Solomon, Z., Mirabal, J., Mazur, D., Kohn, T., Lipshultz, L., Pastuszak, A. (2019). Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sexual Medicine Reviews, 1(7), 84-94.
  4. Bhasin, S., Jasuja, R. (2009). Selective Androgen Receptor Modulators As Function Promoting Therapies. Current Opinion in Clinical Nutrition and Metabolic Care, 3(12), 232-240.
  5. Dalton, J., Barnette, K., Bohl, C., Hancock, M., Rodriguez, D., Dodson, S., … & Steiner, M. (2011). The Selective Androgen Receptor Modulator Gtx‐024 (Enobosarm) Improves Lean Body Mass and Physical Function In Healthy Elderly Men And Postmenopausal Women: Results Of A Double‐blind, Placebo‐controlled Phase II Trial. J cachexia sarcopenia muscle, 3(2), 153-161.
  6. Mohler, M., Bohl, C., Jones, A., Coss, C., Narayanan, R., He, Y., … & Miller, D. (2009). Nonsteroidal Selective Androgen Receptor Modulators (Sarms): Dissociating the Anabolic And Androgenic Activities Of The Androgen Receptor For Therapeutic Benefit. J. Med. Chem., 12(52), 3597-3617.
  7. Panneerselvam, P., Singh, L., Selvarajan, V., Chng, W., Ng, S., Tan, N., … & Ding, J. (2012). T-cell Death Following Immune Activation Is Mediated By Mitochondria-localized Sarm. Cell Death Differ, 3(20), 478-489.
  8. Peng, J., Yuan, Q., Lin, B., Panneerselvam, P., Wang, X., Luan, X., … & Ding, J. (2010). Sarm Inhibits Both Trif- and Myd88-mediated Ap-1 Activation. Eur. J. Immunol., 6(40), 1738-1747.
  9. Yin, D., Gao, W., Kearbey, J., Xu, H., Chung, K., He, Y., … & Dalton, J. (2002). Pharmacodynamics Of Selective Androgen Receptor Modulators. J Pharmacol Exp Ther, 3(304), 1334-1340.